Linden Advisors’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-128,100
Closed -$5.44K 295
2024
Q2
$5.44K Hold
128,100
﹤0.01% 280
2024
Q1
$7.53K Hold
128,100
﹤0.01% 299
2023
Q4
$6.08K Hold
128,100
﹤0.01% 305
2023
Q3
$10.8K Hold
128,100
﹤0.01% 332
2023
Q2
$6K Hold
128,100
﹤0.01% 371
2023
Q1
$16.3K Hold
128,100
﹤0.01% 402
2022
Q4
$10.2K Hold
128,100
﹤0.01% 495
2022
Q3
$16K Hold
128,100
﹤0.01% 607
2022
Q2
$30K Hold
128,100
﹤0.01% 626
2022
Q1
$37K Buy
+128,100
New +$50.7K ﹤0.01% 684

Other funds holding NFYS.WS

Linden Advisors's NFYS.WS Position: Q3 2024 in Review

Linden Advisors sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 128,100 shares — an estimated $5.44K sold.

Linden Advisors first reported a position in NFYS.WS in Q1 2022 and held it in 10 quarters. The position peaked at $37K in Q1 2022. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

  • Linden Advisors reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • Linden Advisors sold 128,100 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $5.44K.
  • Linden Advisors first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 10 quarters.
  • Linden Advisors's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $37K in Q1 2022.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on Linden Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.